Annovis Bio, Inc.
ANVS
$1.57
-$0.07-4.27%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.55M | 12.64M | 4.00M | 3.14M | 5.75M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 367.40K | 254.80K | 313.00K | 4.99M | 41.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.01M | 1.47M | 735.70K | 4.36M | 4.41M |
| Total Current Assets | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M |
|
|
|||||
| Total Current Assets | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M |
|
|
|||||
| Total Accounts Payable | 2.31M | 4.10M | 3.39M | 4.11M | 1.29M |
| Total Accrued Expenses | 1.58M | 1.29M | 662.70K | 763.20K | 2.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.88M | 5.39M | 4.06M | 4.87M | 4.28M |
|
|
|||||
| Total Current Liabilities | 3.88M | 5.39M | 4.06M | 4.87M | 4.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 737.00K | 1.91M | 2.74M | 6.30M | 13.68M |
| Total Liabilities | 4.62M | 7.30M | 6.80M | 11.17M | 17.96M |
|
|
|||||
| Common Stock & APIC | 144.16M | 136.05M | 114.60M | 107.97M | 102.51M |
| Retained Earnings | -134.85M | -128.98M | -116.35M | -111.33M | -110.26M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M |
|
|
|||||